{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T20:20:12Z","timestamp":1778876412875,"version":"3.51.4"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1,24]]},"DOI":"10.7759\/cureus.102197","type":"journal-article","created":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T11:34:04Z","timestamp":1769254444000},"source":"Crossref","is-referenced-by-count":1,"title":["Weekly Liraglutide for the Management of Intractable Polydipsia and Interdialytic Weight Gain in a Patient on Hemodialysis: A Case Report"],"prefix":"10.7759","author":[{"given":"Franklin","family":"Mora-Bravo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pamela T","family":"Morales","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriela","family":"Pincay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samantha","family":"Pineda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brayan","family":"Morales","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3390\/jcm14061846","article-title":"How to limit interdialytic weight gain in patients on maintenance hemodialysis: state of the art and perspectives","volume":"14","author":"Bossola M","year":"2025","unstructured":"Bossola M, Mariani I, Strizzi CT, Piccinni CP, Di Stasio E. How to limit interdialytic weight gain in patients on maintenance hemodialysis: state of the art and perspectives. J Clin Med. 2025, 14:1846. 10.3390\/jcm14061846","journal-title":"J Clin Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.2337\/dc15-1025","article-title":"Safety and efficacy of liraglutide in patients with type 2 diabetes and end-stage renal disease: an investigator-initiated, placebo-controlled, double-blind, parallel-group, randomized trial","volume":"39","author":"Idorn T","year":"2016","unstructured":"Idorn T, Knop FK, J\u00f8rgensen MB, et al.. Safety and efficacy of liraglutide in patients with type 2 diabetes and end-stage renal disease: an investigator-initiated, placebo-controlled, double-blind, parallel-group, randomized trial. Diabetes Care. 2016, 39:206-13. 10.2337\/dc15-1025","journal-title":"Diabetes Care"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1007\/s11255-020-02401-5","article-title":"Thirst in patients on chronic hemodialysis: what do we know so far?","volume":"52","author":"Bossola M","year":"2020","unstructured":"Bossola M, Calvani R, Marzetti E, Picca A, Antocicco E. Thirst in patients on chronic hemodialysis: what do we know so far?. Int Urol Nephrol. 2020, 52:697-711. 10.1007\/s11255-020-02401-5","journal-title":"Int Urol Nephrol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/s40279-017-0800-5","article-title":"Post-exercise ingestion of carbohydrate, protein and water: a systematic review and meta-analysis for effects on subsequent athletic performance","volume":"48","author":"McCartney D","year":"2018","unstructured":"McCartney D, Desbrow B, Irwin C. Post-exercise ingestion of carbohydrate, protein and water: a systematic review and meta-analysis for effects on subsequent athletic performance. Sports Med. 2018, 48:379-408. 10.1007\/s40279-017-0800-5","journal-title":"Sports Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1111\/dom.14409","article-title":"Intensive management of obesity in people with severe chronic kidney disease: a review","volume":"23","author":"Song R","year":"2021","unstructured":"Song R, Nolan BJ, Harb H, Sumithran P. Intensive management of obesity in people with severe chronic kidney disease: a review. Diabetes Obes Metab. 2021, 23:1733-45. 10.1111\/dom.14409","journal-title":"Diabetes Obes Metab"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1111\/dom.16484","article-title":"Efficacy and tolerance of liraglutide for weight loss in obese, type 2 diabetes and haemodialysis patients","volume":"27","author":"Touzot M","year":"2025","unstructured":"Touzot M, Voican A, Potier L, et al.. Efficacy and tolerance of liraglutide for weight loss in obese, type 2 diabetes and haemodialysis patients. Diabetes Obes Metab. 2025, 27:4599-602. 10.1111\/dom.16484","journal-title":"Diabetes Obes Metab"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1186\/1758-5996-5-10","article-title":"The efficacy of incretin therapy in patients with type 2 diabetes undergoing hemodialysis","volume":"5","author":"Terawaki Y","year":"2013","unstructured":"Terawaki Y, Nomiyama T, Akehi Y, et al.. The efficacy of incretin therapy in patients with type 2 diabetes undergoing hemodialysis. Diabetol Metab Syndr. 2013, 5:10. 10.1186\/1758-5996-5-10","journal-title":"Diabetol Metab Syndr"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1152\/ajpregu.00087.2025","article-title":"The antidipsogenic action of nesfatin-1 requires activation of a GLP-1 receptor","volume":"329","author":"Bocke CR","year":"2025","unstructured":"Bocke CR, Yosten GL, Samson WK. The antidipsogenic action of nesfatin-1 requires activation of a GLP-1 receptor. Am J Physiol Regul Integr Comp Physiol. 2025, 329:R253-7. 10.1152\/ajpregu.00087.2025","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.appet.2022.105943","article-title":"Control of water intake by a pathway from the nucleus of the solitary tract to the paraventricular hypothalamic nucleus","volume":"172","author":"Volcko KL","year":"2022","unstructured":"Volcko KL, Brakey DJ, McNamara TE, Meyer MJ, McKay NJ, Santollo J, Daniels D. Control of water intake by a pathway from the nucleus of the solitary tract to the paraventricular hypothalamic nucleus. Appetite. 2022, 172:105943. 10.1016\/j.appet.2022.105943","journal-title":"Appetite"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.hrtlng.2024.04.012","article-title":"Non-pharmacological interventions to reduce thirst in patients with heart failure or hemodialysis: a systematic review and meta-analysis","volume":"67","author":"Wefer F","year":"2024","unstructured":"Wefer F, Kr\u00fcger L, Waldr\u00e9us N, K\u00f6pke S. Non-pharmacological interventions to reduce thirst in patients with heart failure or hemodialysis: a systematic review and meta-analysis. Heart Lung. 2024, 67:33-45. 10.1016\/j.hrtlng.2024.04.012","journal-title":"Heart Lung"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1159\/000094334","article-title":"Glucagon-like peptide-1 is involved in sodium and water homeostasis in humans","volume":"73","author":"Gutzwiller JP","year":"2006","unstructured":"Gutzwiller JP, Hruz P, Huber AR, et al.. Glucagon-like peptide-1 is involved in sodium and water homeostasis in humans. Digestion. 2006, 73:142-50. 10.1159\/000094334","journal-title":"Digestion"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-020-02394-2","article-title":"Effects of glucagon-like peptide-1 receptor agonists on fluid intake in healthy volunteers","volume":"70","author":"Winzeler B","year":"2020","unstructured":"Winzeler B, da Concei\u00e7\u00e3o I, Refardt J, Sailer CO, Dutilh G, Christ-Crain M. Effects of glucagon-like peptide-1 receptor agonists on fluid intake in healthy volunteers. Endocrine. 2020, 70:292-8. 10.1007\/s12020-020-02394-2","journal-title":"Endocrine"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1172\/JCI151800","article-title":"A randomized controlled trial of the GLP-1 receptor agonist dulaglutide in primary polydipsia","volume":"131","author":"Winzeler B","year":"2021","unstructured":"Winzeler B, Sailer CO, Coynel D, et al.. A randomized controlled trial of the GLP-1 receptor agonist dulaglutide in primary polydipsia. J Clin Invest. 2021, 131:e151800. 10.1172\/JCI151800","journal-title":"J Clin Invest"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/455710-weekly-liraglutide-for-the-management-of-intractable-polydipsia-and-interdialytic-weight-gain-in-a-patient-on-hemodialysis-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T11:34:05Z","timestamp":1769254445000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/455710-weekly-liraglutide-for-the-management-of-intractable-polydipsia-and-interdialytic-weight-gain-in-a-patient-on-hemodialysis-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,24]]},"references-count":13,"URL":"https:\/\/doi.org\/10.7759\/cureus.102197","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1,24]]}}}